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Abstract
Background
The objective of this review was to evaluate the use of all direct and indirect methods used
to estimate health utilities in both children and adolescents. Utilities measured pre- and
post-intervention are combined with the time over which health states are experienced to
calculate quality-adjusted life years (QALYs). Cost-utility analyses (CUAs) estimate the
cost-effectiveness of health technologies based on their costs and benefits using QALYs as
a measure of benefit. The accurate measurement of QALYs is dependent on using appro-
priate methods to elicit health utilities.
Objective
We sought studies that measured health utilities directly from patients or their proxies. We
did not exclude those studies that also included adults in the analysis, but excluded those
studies focused only on adults.
Methods and Findings
We evaluated 90 studies from a total of 1,780 selected from the databases. 47 (52%) stud-
ies were CUAs incorporated into randomised clinical trials; 23 (26%) were health-state utility
assessments; 8 (9%) validated methods and 12 (13%) compared existing or new methods.
22 unique direct or indirect calculation methods were used a total of 137 times. Direct calcu-
lation through standard gamble, time trade-off and visual analogue scale was used 32
times. The EuroQol EQ-5D was the most frequently-used single method, selected for 41
studies. 15 of the methods used were generic methods and the remaining 7 were disease-
specific. 48 of the 90 studies (53%) used some form of proxy, with 26 (29%) using proxies
exclusively to estimate health utilities.
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Conclusions
Several child- and adolescent-specific methods are still being developed and validated,
leaving many studies using methods that have not been designed or validated for use in
children or adolescents. Several studies failed to justify using proxy respondents rather
than administering the methods directly to the patients. Only two studies examined missing
responses to the methods administered with respect to the patients’ ages.
Introduction
Rationale
Evaluation of healthcare interventions and technologies commonly assess both the cost and
consequences of interventions, in addition to effectiveness and safety. Economic evaluations
are increasingly being used by healthcare systems around the world before a decision is made
on whether to recommend a new intervention. In the United Kingdom, for example, the
National Institute for Health and Care Excellence (NICE) requires that the appraisal of new
interventions and technologies includes a cost-effectiveness analysis containing an assessment
of benefits and resource use [1]. A requirement in the evidence submitted is a cost-utility analy-
sis (CUA) that compares costs with benefits using quality-adjusted life years (QALYs), a mea-
sure incorporating the length of life and quality of life.
Quality of life is measured using health utilities that take values between 0 and 1, corre-
sponding to utilities for dead and perfect health respectively. These utilities measured pre- and
post-intervention are combined with the time over which the health states are experienced to
calculate the QALYs that can be gained from new interventions. When evaluating several new
health technologies the ratio of expected additional total costs to the expected additional
QALYs gained incrementally is estimated for each technology, then cost-effectiveness is evalu-
ated by comparing the incremental cost-per-QALY ratio against a pre-determined cost-effec-
tiveness threshold, which in the UK is between £20,000 and £30,000 per QALY gained [1].
A CUA is also the recommended economic evaluation for submissions to the Canadian
Agency for Drugs and Technologies in Health (CADTH) [2]; in Australia with submissions to
The Pharmaceutical Benefits Advisory Committee (PBAC) [3]; in Sweden with submission to
The Swedish Council on Health Technology Assessment (SBU) [4]; in New Zealand with sub-
missions to The Pharmaceutical Management Agency (PHARMAC) [5] and other countries
[6].
Health state utility values are usually obtained from one of two sources. Either the relevant
health states are directly valued, using techniques such as Time Trade Off (TTO) or Standard
Gamble (SG), or an existing tariff is applied. This latter approach is generally used when valu-
ing generic health states (such as the EuroQol EQ-5D [7]). The tariff to be applied is usually
based on valuations of a general population sample again using techniques such as TTO and
SG. The TTO is a choice-based method that establishes for an individual how much time in
full health is equivalent to a specified period of time spent in a particular ill-health state. The
SG is another choice-based method that identifies the probability of being in a better health
state that makes an individual indifferent between the certainty of being in an intermediate
health and a gamble between a worse health state and a better health state.
Measuring utilities for health-related quality of life (HRQoL) for children and adolescents is
a developing field of research. Methods used to obtain health utilities from adults are well
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established but many have not been validated for use in children and adolescents. NICE states
that the EQ-5D is the preferred method for use in CUAs that focus on the adult population [1],
but no specific guidance has been given to help health economists choose an instrument
designed for children and adolescents. Indeed, NICE did not make a specific recommendation
for a particular instrument in the publication of their most recent guidance on technology
appraisal [1].
There is evidence that children and adolescents are able to report on the state of their own
health [8]. Children aged 3 years can report on feelings of nausea and pain that are reliable and
clinically meaningful [9–11]. If children can convey the state of their health using a standard-
ised method such as EQ-5D or HUI-2 then accurate and meaningful health utilities may be
obtained for a range of childhood illnesses and conditions, which would be highly desirable for
conducting CUAs.
It is important to recognise that methods suitable for young children may not be applicable
to adolescents [12, 13], in the same way that adult-specific methods may not be appropriate for
recording health utilities of adolescents [14]. Children may lack the cognitive ability to evaluate
their health using abstract concepts in adult-specific indirect methods and direct methods such
as TTO and SG. In addition, young children may lack the required linguistic skills to answer
questions about their preferences for health using systems designed for self-completion by
older children. The understanding of disease and its effect on HRQoL changes with the child’s
age, consequently both the measurement and valuation of changes in health due to disease
need to be facilitated using age-specific instruments [12, 15].
Some methods have been developed for use exclusively in children and adolescents, and
some existing adult-specific methods have been modified to make them child-friendly. The
EQ-5D has been amended so that the questions for each dimension of health are easier to read
and more accessible to children, resulting in a new child-friendly method called the EQ-5D-Y
[16]. However, this uses the same utility weights in each dimension as the adult version, so
does not yet incorporate child and adolescent preferences for health states. Adult preferences
for health states may be different from the preferences of children and adolescents and the
dimensions included may not cover all dimensions of health relevant to children and adoles-
cents [17].
Generic and disease-specific calculation methods. Direct and indirect methods for the cal-
culation of health utilities fall into two distinct domains–generic and disease-specific. Generic
methods can be used to measure HRQoL in adults, children and adolescents (where appropri-
ate) for a range of conditions, both chronic and acute. Commonly used generic methods
include the EQ-5D and HUI-2. Disease-specific methods measure HRQoL with reference to a
particular condition, such as the Asthma Control Questionnaire (ACQ) [18] and the Pediatric
Asthma Health Outcome Measure (PAHOM) [19].
The advantage of using generic calculation methods in CUAs is that results can be com-
pared across populations, conditions, and for different treatments or interventions [20]. Dis-
ease-specific methods have the benefit of being more sensitive to small changes in the
condition of the patient in question and may describe the functioning of a patient with the con-
dition with greater clarity than a generic classification system that may overlook some aspects
of HRQoL [21], but utilities calculated using these instruments lack comparability across dif-
ferent diseases.
Measurement by proxy.When measuring the HRQoL of young children some authors pre-
fer to gather the health utilities via proxies as young children may not have the cognitive ability
to evaluate their health and/or complete the required measurement tasks [17]. Proxy respon-
dents include the child’s parents, clinicians and teachers. Parents are deemed to be the most
useful proxies as they are the most familiar with their child’s health and life [22, 23], though it
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has been suggested that parents may misjudge the health of their child owing to their own anxi-
ety during the illness [24, 25] and further studies have shown differences between parent and
child ratings for the child’s health [26–28]. Clinicians’ knowledge of children’s conditions,
symptoms, and functioning makes them useful proxies when evaluating HRQoL, though they
will not have the same contact with children during their time away from clinics at home or in
school [22, 29] so results are of questionable validity [30]. Teachers will not be able to provide
HRQoL assessments for the child at home or in clinics [22] but will be able to evaluate a child’s
emotional and physical functioning.
In a systematic review published in 2005, Griebsch et al. [31] concluded that methods for
measuring health utilities in children need further development. They noted the lack of meth-
ods that account for the development of the child, methods for children aged younger than 5
years, and a full understanding of the role of proxies in the evaluation of HRQoL in children
and adolescents. Ravens-Sieberer et al. (2006) concluded that HRQoL of children and adoles-
cents can and therefore should be ascertained by self-rating [32].
When performing a CUA in children and adolescents researchers must determine the best
way to obtain utilities: expert opinion, measurement using patients or measurement using prox-
ies. Each option will impose limitations on the study, and if the protocol calls for measurement
then the researchers need to choose the appropriate method. The method used in CUAs should
be justified as each has limitations relevant to the estimation of health utilities and QALYs.
Objective
The objective of this review was to evaluate the application of direct and indirect methods used
to measure health-related quality of life in children and adolescents. In doing so, we aimed to
answer the following questions:
1. What direct and indirect methods have been used to obtain health utilities from children
and adolescents? How frequently have they been used?
2. If the method has not been validated for use in the study population do the authors
acknowledge the limits of the method and therefore the study?
3. For study populations that include adults with children and adolescents, did the younger
participants complete the calculation method to the same level as the adult participants?
4. When proxies have been used to obtain health utilities have the authors acknowledged the
problems related to obtaining such utilities from proxies rather than patients?
Previous reviews
Kromm et al. (2012) [14] used the Pediatric Economic Database Evaluation (PEDE) project’s
online database to find a total of 213 CUAs for children and adolescents published in English
between 1997 and 2009 to use in a quality appraisal. Citing that CUAs were 8% of all published
economic evaluations between 1976 and 2001 [33] and also that 10% of economic evaluations
for children and adolescents published between 1980 and 1999 were CUAs [34], they assessed
the quality of such CUAs using the 57-item Pediatric Quality Appraisal Questionnaire
(PQAQ) [35]. Only 16 (8%) of the studies included in the review gathered health utilities as
part of the analysis (Table 1).
Other studies used health utilities from the researchers or literature (63%), health care pro-
vider opinion (6%), disability-adjusted life years (DALYs) (25%) and the remainder did not
state the source of the utilities (1%). Kromm et al. (2012) argued that utilities gathered from
the published literature might not be valid [36]. Study authors may assume that adult health
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utilities apply to children and adolescents and assume a uniform utility throughout childhood
and adolescence, ignoring the child’s development [12, 13]. In conclusion, the authors stated
that new instruments should be developed to obtain utilities from children, rather than relying
on adult utilities from the literature and utilities gathered via proxy.
Ladapo et al. (2007) [37] concentrated on CUAs in the United States, comparing analyses
for adult, children and adolescent interventions. Using a database developed by the Tufts-New
England Medical Center in Boston, they compared various aspects of 35 CUAs for children
and adolescents with 491 adult CUAs. They found that generic classification systems (EQ-5D,
Quality of Well Being (QWB) and HUI only) were used in 29% of analyses for children and
adolescents and such CUAs are methodologically similar to adult CUAs. The leading primary
disease category for CUAs for children and adolescents was infectious, representing 31% of all
such CUAs. Finally, the authors noted that published cost-utility ratios tend to be lower for
children and adolescents than for adults.
Griebsch et al. (2005) [31] considered all CUAs for patients aged younger than 17 years
published until April 2004 in the Medline, Embase, Econlit, York Database of Abstracts of
Reviews of Effectiveness, NHS Economic Evaluation Database, the Harvard Cost-Utility Anal-
ysis Database and the Database of the PEDE project. 63 direct or indirect calculation methods
were used to estimate health utilities, of which 22 (35%) used a generic method. The authors
concluded that the variation in methods for estimating health utilities in children and adoles-
cents meant that the process was not yet standardised. They called for the clear justification of
the choice of methods for measurement.
Recently, Adlard et al. (2014) [38] discussed how the practice of paediatric CUAs has
evolved over time, with reference to methods described in the NICE reference case [1]. The
review considered 43 studies published between May 2004 and April 2012, of which only 11
obtained health utilities from children with the remaining 32 studies using utilities published
in the literature. The authors noted that since NICE suggested investigators use the HUI-2 to
obtain health utilities from children there has been no increase in use of this instrument, with
many authors seeking to use the EuroQol EQ-5D or its derivatives. Adlard et al. recommended
that research funding be targeted at those studies seeking to estimate health utilities directly
from children, given a lack of published data specific to this age group and wide variation in
the methods used to obtain these data in previous work.
In contrast to the reviews cited, this review examined the methods used by researchers and
health economists to estimate health utilities for children and adolescents and the extent of the
variation between them. Details of all methods administered in each study were collated to
evaluate the suitability of each system given the age of study participants, mode of completion
and the stated justification for use of each calculation method.
Table 1. Results from Kromm et al. (2012) [14] for studies that measured health utilities as part of the CUA.
Were health utilities measured
in the study?
From whom? Direct measurement methods used Indirect measurement methods used
Yes (n = 16)
Child (n = 5) Time trade-off EuroQol EQ-5D
Parent as proxy (n = 10) Standard Gamble, Time trade-off, Visual
Analogue Scale
EuroQol EQ-5D, Health Utilities Index, Quality
of Well-Being Scale
Health care provider as
proxy (n = 3)
None EuroQol EQ-5D, Health Utilities Index, 16D-
questionnaire
Adults as proxy (n = 1) Time trade-off None
Parent as unit of analysis
(n = 1)
Time trade-off None
doi:10.1371/journal.pone.0135672.t001
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Methods
Eligibility criteria
Studies eligible for inclusion in the final review needed to include primary data to measure
health utilities from patients aged 17 years or under, through the administration of at least one
direct or indirect method completed by either the patients or their proxies. Studies that
included adult patients were not excluded, but studies that gathered HRQoL data exclusively
from adults were excluded. We did not exclude studies based on language of publication, date
of publication, journal or disease.
Studies that used other methods to calculate HRQoL scores that are incapable of generating
utilities without a further mapping process were excluded unless the study also used a method
to calculate health utilities.
Eligibility was not restricted to CUAs using primary data for HRQoL; studies detailing the
validation of methods and studies that calculated health utilities for specified conditions but
stopped short of collecting data related to healthcare resource use and patient-borne costs to
calculate a cost-per-QALY ratio were eligible for inclusion.
Studies using health utilities gathered from previous studies were excluded, as were reviews,
comment pieces and conference abstracts. All studies included in the full-text review had their
references checked for additional studies to include in the review that did were not found
through the online database search.
Information sources
We searched for articles in the following databases: CAB Abstracts, Global Health, Ovid MED-
LINE(R), Econlit and Embase Classic+Embase.
Search
The search terms were taken from a systematic review published in 2005 by Griebsch et al.
[31], appraising published CUAs in child and adolescent health care and looking at further
issues still in doubt within the measurement of HRQoL in children and adolescents:
1. Infant, newborn/
2. Infant/
3. Child, preschool/
4. Child/
5. Adolescent/
6. 1 or 2 or 3 or 4 or 5
7. expand quality-adjusted life years/
8. cost-utility or cost utility
9. cost-effectiveness or cost effectiveness
10. 7 and 9
11. 8 or 10
12. 11 and 6
The search was performed on 30th September 2014.
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Data items
The following data were extracted from papers included in the full-text review:
• Reference
• Year of publication
• Country
• Direct or indirect calculation method(s) used
• Health condition (if applicable)
• Sample size
• Age range of participants
• Mode of assessment:
 Self-completion of questions
 Completion of questions via proxy (parents, clinicians, primary caregivers, etc.)
 Patient interviews
 Interviews with proxies (parents, clinicians, primary caregivers, etc.)
 Other methods
 Methods not stated
• Study type:
 Validation of calculation method
 CUA
 Health utility assessment
 Comparison of calculation methods
We classified each study as one of four study types by the primary aim of each study: valida-
tions of calculation methods sought to validate or derive an instrument for estimating health
utilities; CUAs first estimated health utilities then used these utilities in an economic evalua-
tion; health utility assessments measured the burden of disease in individuals using health utili-
ties; and comparisons of calculation methods used two or more instruments to measure health
utilities then compared results.
In addition, each paper was analysed to ascertain whether or not the method(s) used had
been justified for use in the cohort, along with the acknowledgment of any data collection
issues that were related to the participants’ understanding of the calculation method.
Results
Study selection: 1,780 studies were retrieved from an online database search and were imported
into an EndNote X7 library. 433 studies were removed from the list as duplicates. The remain-
ing 1,347 studies underwent a title, abstract and type of publication review to exclude studies
that did not meet the inclusion criteria. The remaining 227 studies were submitted for a full-
text review. 150 studies were excluded from the full-text review as they did not use direct or
indirect methods to gather primary data for HRQoL in children and adolescents, whilst an
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additional 13 studies were found in the list of references. In total, 90 studies were included in
the review (Fig 1).
The earliest publication date for a study included in the review was 1994 (Fig 2). Since then
the publication of measurements of health utilities in children and adolescents has steadily
increased. The year with the most publications was 2010.
25 different countries were featured in the studies included in the review (Fig 3). The UK
was featured the most. Three studies included multiple countries [39–41].
Study characteristics
47 studies (52.2% of 90) were CUAs of which 21 [42–62] (44.7% of 47) were incorporated into
randomised controlled trials for interventions. 23 [39, 40, 63–83] studies (25.6% of 90) were
health-state utility assessments. Eight [19, 84–90] studies (8.9% of 90) were validations of cal-
culation methods. The remaining 12 [62, 91–101] studies (13.3% of 90) were comparisons of
calculation methods. 11 studies (12.2% of 90) had secondary aims of either comparing calcula-
tion methods (seven studies [62, 69, 71, 75, 77, 84, 88]) or providing health-state utility assess-
ments (four studies [19, 41, 93, 102]).
The 90 studies used 22 unique calculation methods to gather health utilities, with the total
frequency of use in all studies being 137. 7 calculation methods were disease-specific and were
used 11 times (8.0% of 137) in all. The 15 generic calculation methods were used 126 times
(92.0% of 137).
The EuroQol collection of indirect calculation methods was the most widely used, accounting
for 38.0% of the total frequency of use (Table 2). The EQ-5Dwas used 41 times with its derivatives
the EQ-5D-Y (used 10 times) and EQ-5D+ (a modification of the EQ-5D to include an additional
dimension for cognitive functioning, used once) used separately. Direct calculation methods were
also common, used 24.4% of the time. The stand-alone Visual Analogue Scale (VAS) was used 14
times, with the direct calculation methods of the SG and TTO each used nine times. The Health
Utilities Index collection of indirect calculation methods was used 26 times (Table 3).
Fig 1. Identification of studies of measuring HRQoL in children and adolescents.
doi:10.1371/journal.pone.0135672.g001
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11 studies did not specify the age range of all participants. Four of these studies stated the
mean age of participants; one study used a hypothetical cohort of child and adolescent patients
but did not specify any demographic details of this hypothetical cohort; three did not give any
details of the ages at all but the title and/or study details refer to child and adolescent patients;
the three remaining studies indicated in aggregated results tables that some children and ado-
lescents participated without elaboration of demographic details.
The number of participants varied from small studies of six children and adolescents [103]
to studies sampling from large national databases of patients that included 84,443 patients of
all ages [65] in their evaluation.
35 studies gathered health utilities exclusively from child and adolescent patients. 48 studies
administered the calculation methods to adults whilst the remaining seven studies did not specify
the age range of patients or did not present enough detail about the age range to determine the
overall age of the cohort. 10 studies did not specify how the calculation methods were completed.
Fig 2. Year of publication for studies included in the review.
doi:10.1371/journal.pone.0135672.g002
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Analysis of the use of different calculation methods
Measurement by proxy. 54 studies administered calculation methods directly to children
and adolescents in line with previous recommendations that they are able to evaluate their own
health states [8–11], although 22 of these also used at least one method of proxy completion for
at least one of the calculation methods. Of these 22 studies, 16 used parental proxies; four used
clinician proxies; and three used caregiver proxies.
26 studies used proxies exclusively, with 17 using parental proxies, six using clinician prox-
ies and five other proxies. One study used a combination of different proxies to obtain health
utilities.
Some studies commented on the use of proxies to obtain health utilities: Cheng et al. (2000)
[123] acknowledged that proxy reporting may overestimate health utility gains for cochlear
implants; Chiou et al. (2005) [19] discussed issues around the use of parental proxies in their
study, stating that parental preference for health may be different from child preferences;
Jelsma & Ramma (2010) [97] recommended the use of self-reporting rather than proxy-report-
ing, acknowledging the potential issues with proxy-reporting; Oostenbrink et al. (2002) [100]
stated that health utilities for CUAs should be measured from patients rather than proxies, as
Fig 3. Countries featured in studies using direct or indirect calculation methods for obtaining health
utilities from paediatric patients.
doi:10.1371/journal.pone.0135672.g003
Table 2. Frequency of use for calculationmethods found during the review.
Family of calculation method Number of methods in family Frequency of use
Direct Calculation 3 32
EuroQol 3 52
Health Utilities Index 2 26
Short Form 3 8
Other 11 19
22 137
doi:10.1371/journal.pone.0135672.t002
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proxies may have difficulty evaluating the impact of conditions on dimensions of health such
as pain and emotion; Tilford et al. (2005) [79] called for more research to be conducted on cal-
culation methods for young child when discussing the issues surrounding the use of proxies;
Tilford et al. (2012) [102] cite the use of proxies as a limitation in their study; Wasserman et al.
(2005) [82] acknowledged a potential discrepancy between patient- and proxy-reported health
utilities in their study.
However, several other studies argued that proxy-reporting was appropriate: Bichey et al.
(2002) [124] said that clinician-proxy was suitable due to the clinicians’ familiarity with each
case; Bodden et al. (2008) [42] referred to previous studies that used EQ-5D through proxies;
Chadha et al. (2010) [93] stated that their results showed no difference between self- and
proxy-reported utilities; Friedman et al. (2004) [64] claimed that parental-proxy is consistent
in evaluating HRQoL for children with atopic dermatitis; Gerald et al. (2012) [88] claimed that
clinician-proxy reporting of health utilities is the gold standard; Hollman et al. (2013) [67]
refered to previous studies to justify their use of proxy-reporting; Matza et al. (2005) [71]
claimed that SG methods through parental-proxies are a suitable method for obtaining health
utilities from children; Petrou & Kupek (2009) [73] claimed that there is no consistent evidence
that parental- or caregiver-proxies either over-estimate or under-estimate health utilities for
their children; Poley et al. (2001) [125] cite previous studies to support the use of proxies. van
Litsenburg et al. (2013) stated that the HUI-3 calculation method is a parental-proxy method
by design [81].
Use of child- or adolescent-specific calculation methods. Six calculation methods found
in this review were designed specifically for use in the child and/or adolescent population
(Table 4). The number of health dimensions included ranges from three to nine. Three
Table 3. Direct and indirect calculationmethods to obtain health utilities from the paediatric population.
Abbreviation Methods of obtaining utilities Generic or disease-speciﬁc Frequency of use
15D 15D Instrument [104] Generic 1
ACQ Asthma Control Questionnaire [105] Disease speciﬁc 3
AQoL-6D Assessment of Quality of Life 6D [106] Generic 1
CAVE Escala de calidad de vida del niño con epilepsia [107] Disease speciﬁc 1
CHU-9D Child Health Utility 9D [108] Generic 3
EQ-5D EuroQol 5D [109] Generic 41
EQ-5D+ Expanded EuroQol 5D Disease speciﬁc 1
EQ-5D-Y EuroQol 5D Youth Version [110] Generic 10
HALex Health and Activities Limitation Index [111] Generic 1
HUI-2 Health Utilities Index 2 [112] Generic 10
HUI-3 Health Utilities Index 3 [112] Generic 16
Mini AQLQ Mini Asthma Quality of Life Questionnaire [113] Disease speciﬁc 2
PAHOM Pediatric Asthma Health Outcome Measure [19] Disease speciﬁc 2
PAQLQ Paediatric Asthma Quality of Life Questionnaire [114] Disease speciﬁc 1
QLQ-C30 EORTC Quality of Life Questionnaire-Core 30 [115] Disease speciﬁc 1
QWB Quality of Well Being [116] Generic 3
SF-12 Short Form 12 [117] Generic 2
SF-36 Short Form 36 [118] Generic 4
SF-6D Short Form 6D [119] Generic 2
SG Standard Gamble [120] Generic 9
TTO Time Trade Off [121] Generic 9
VAS Visual Analogue Scale [122] Generic 14
doi:10.1371/journal.pone.0135672.t003
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methods are disease-specific with two focusing on asthma and one focusing on epilepsy. The
remaining three methods are generic systems.
Some studies discussed the short-comings of the calculation methods used. For example,
Canaway et al. (2012), Oluboyede et al. (2011) and Wu et al. (2010) all discussed the lack of an
appropriate tariff for the EQ-5D-Y [83, 92, 99], acknowledging that existing utilities have been
taken from the adult-specific EQ-5D, finally stating that the current EQ-5D-Y is not yet com-
plete without the child-focused tariff. Thorrington et al. (2014) also commented on the lack of
a child-specific tariff for the EQ-5D-Y [78]. It has previously been noted by Kromm et al.
(2012) [14] that slow progress is being made in developing age-specific utility weights.
Many other studies opted to administer calculation methods designed for a wide range of
ages, such as the HUI-2 or the HUI-3. In addition, the EQ-5D system (originally designed for
use in adults) was used 41 times, with the child-specific EQ-5D-Y version used only 10 times.
Few studies adopting this approach discussed the suitability of their methods by evaluating the
number of missing values for each returned calculation method. Hollmann et al. (2013) [67],
Jelsma (2010) [96], Radford et al. (2013) [53], Thorrington et al. (2014) [78] Tilford et al.
(2012) [102] and Wyatt et al. (2012) [62] all present data for missing or incomplete responses
for their respective calculation methods, but only Jelsma (2010) [96] and Thorrington et al.
(2014) [78] discuss these data with respect to the age of the respondents.
Discussion
Summary of evidence
There is extensive variation in the methods used to estimate health utilities from children and
adolescents. Issues that were raised by Kromm et al. (2012) and Griebsch et al. (2005) relating
to the need for a standardised method to collect health utilities from children and adolescents
are yet to be fully resolved. Though this review found 22 different calculation methods that
have been used between 1994 and 2013, many adult-specific methods have been used with chil-
dren and adolescents without justification. Although several child- and adolescent-specific
methods are currently in development, some existing adult-specific systems have been modi-
fied in order to fill the current gap.
Table 4. List of child- and/or adolescent-specific calculation methods used.
Abbreviation Name of calculation
method
Age range and mode of
completion
Dimensions of health Studies found
using this
method
AQoL-6D Assessment of quality of
life (adolescent version)
15–17 years, Self-completion Independent living, Relationship, Mental health,
Coping, Pain, Senses
[68]
CAVE Escala de calidad de
vida del niño con
epilepsia
< 17 years, Self-completion, but
proxy-completion for younger
children
Behaviour, School compliance, Learning, Autonomy,
Social relations, Frequency of seizures, Intensity of
seizures, Parents opinions
[126]
CHU-9D Child health utility, 9
dimensions
7–17 years, Self-completion,
but proxy-completion for
younger children
Worried, Sad, Pain, Tired, Annoyed, School work,
Sleep, Daily routine, Joining with activities
[89, 90, 92]
EQ-5D-Y EuroQol 5 dimensions,
youth version
8–15 years, Self-completion Mobility, Self-care, Usual activities, Pain or
discomfort, Worried, sad or unhappy
[63, 78, 80, 83,
86, 92, 94, 96, 97,
99]
PAQLQ Paediatric asthma quality
of life questionnaire
7–17 years, Self-completion Symptoms, Activity limitations, Emotional function [66]
PAHOM Pediatric asthma health
outcome measure
7–12 years, Self-completion Symptoms, Emotion, Activity [19, 88]
doi:10.1371/journal.pone.0135672.t004
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Current child- and adolescent-specific calculation methods. This review found six calcu-
lation methods designed for use in children and adolescents of which the most frequently used
was the EQ-5D-Y, used 10 times. Another 16 methods either designed for a wide range of ages
or designed specifically for use in adults but applied to younger patients. Development and use
of child- and adolescent-specific methods is steadily increasing, though several issues of suit-
ability still surround these methods. For example, this review found that the EQ-5D-Y has
been used ten times even though the EQ-5D-Y does not differentiate between adult and child
or adolescent preferences for health. Several authors acknowledge this discrepancy with some
calling for further research and development of child- and adolescent-specific calculation
methods. At the time of writing, EuroQol has not explored child-specific utility weights that
use children’s preference for health states for use in the EQ-5D-Y [110].
Use of proxy respondents. Justification for the use of proxy respondents was mixed, and
there is no consensus for the advisability of proxy-reporting in obtaining health utilities from
children and adolescents. Several studies stated that proxy-reporting may differ from self-
reporting in their studies, but others claimed that their use of proxy-reporting was justified by
citing previous CUAs or health utility measurements. Some studies in this review did not dis-
cuss the use of proxy-reporting vs. self-reporting and how their results may have been influ-
enced by proxy reporting from different sources.
The use of proxies has been justified because of lack of verbal capacity of the children being
evaluated [17]. Nevertheless responses should be elicited directly from those children being
evaluated when verbal capacity is not a barrier [32].
Using multiple calculation methods and respondents.Only four studies compared self-
and proxy- reported health utilities. Chadha et al. 2010 [93] found no difference between utili-
ties. Gerald et al. (2012) [88] reported that PAHOM scores for parental proxies were signifi-
cantly lower than self-reported scores from children. Jelsma & Ramma (2010) [97] found
agreement with the EQ-5D-Y scores. Lock et al. (2010) [47] presented the mean and range of
estimated utilities but did not perform a statistical test to verify that self-reported scores were
different to proxy-reported scores.
Missing data. Discussions of missing data are essential in any study. In the case of the EQ-
5D, a missing response to any of the five dimensions of health means that the response cannot
be converted into a health utility. Analysis of missing responses would be helpful in deducing
which aspects of measuring HRQoL in children and adolescents are particularly difficult and
in developing new systems to minimise missing data in responses.
Reliance on adult-specific calculation methods. Perhaps because the EQ-5D-Y still needs
an appropriate tariff for children and adolescents, some authors continue to use an adult-spe-
cific method for children and adolescents in preference to a method under development for the
appropriate age group. The first use of the EQ-5D-Y in this review was in 2009 [94], and since
then 18 studies have used the standard EQ-5D system in children and adolescents or patients
outside of the appropriate age range for the system [41, 45, 48, 51–56, 60, 61, 67, 70, 73, 84, 91,
127, 128].
Limitations of this review
This review only concerned published literature, which may be a source of bias as the gray liter-
ature was not considered. However, Griebsch et al. (2005) [31] argued that by not including
unpublished works, they avoided reducing the overall quality of studies included in their
review.
It was the decision of the authors that focused the qualitative assessment on the use and jus-
tification of different calculation methods to measure HRQoL in children and adolescents.
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There are several other ways to assess the quality of a CUA, notably the PQAQ [35] and the
checklist for economic analysis outlined by Drummond et al. (2005) [129]. However, we have
not sought to assess the quality of each CUA in the review but instead to evaluate the use of
each direct or indirect calculation method in addition to understanding the justification for dif-
ferent methods of eliciting health utilities from children and adolescents.
Conclusions
Many authors examining child and adolescent HRQoL have relied on tools developed exclu-
sively for adults. Further development of child- and adolescent-specific calculation methods is
required to ensure that CUAs using health utilities of children and adolescents are valid, with-
out relying on the assumption that adults, children and adolescents all have the same health
preferences.
Previous studies measuring HRQoL in children and adolescents have relied on proxy
respondents without sufficient justification for their use. There is considerable debate in the lit-
erature about whether proxies can be used (and if so, which proxies). No clear consensus was
found in the literature from this.
Several calculation methods are in development that will facilitate the measurement of
QALYs in children. These systems are needed by health economists as the application of adult-
specific systems is of questionable validity. Adults, children and adolescents measure HRQoL,
perceive and value health differently, so the assumption that adult-specific health utilities are
valid in adolescents or young children is potentially misleading.
Measuring children’s health states is extremely challenging and requires a suitable instru-
ment for the estimation of paediatric health utilities that NICE can recommend for use to
ensure the validity of future child- and adolescent-focused CUAs.
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